These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38925638)

  • 1. "Keep it a secret": leaked documents suggest Philip Morris International, and its Japanese affiliate, continue to exploit science for profit.
    Braznell S; Laurence L; Fitzpatrick I; Gilmore AB
    Nicotine Tob Res; 2024 Jun; ():. PubMed ID: 38925638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQOS: examination of Philip Morris International's claim of reduced exposure.
    St Helen G; Jacob Iii P; Nardone N; Benowitz NL
    Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revolution or redux? Assessing IQOS through a precursor product.
    Elias J; Dutra LM; St Helen G; Ling PM
    Tob Control; 2018 Nov; 27(Suppl 1):s102-s110. PubMed ID: 30305324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heated tobacco products likely appeal to adolescents and young adults.
    McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Document analysis of the Foundation for a Smoke-Free World's scientific outputs and activities: a case study in contemporary tobacco industry agnogenesis.
    Legg T; Clift B; Gilmore AB
    Tob Control; 2024 Jun; 33(4):525-534. PubMed ID: 37137700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying misleading corporate narratives: The application of linguistic and qualitative methods to commercial determinants of health research.
    Fitzpatrick I; Bertscher A; Gilmore AB
    PLOS Glob Public Health; 2022; 2(11):e0000379. PubMed ID: 36962495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering Philip Morris International's Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame.
    Charoenca N; Kungskulniti N; Hamann S; Mock J
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3789-3801. PubMed ID: 34967557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.
    Glantz SA
    Tob Control; 2018 Nov; 27(Suppl 1):s9-s12. PubMed ID: 30131374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philip Morris International's Formula 1 Sponsorship-Linked Marketing: Transformation From Marlboro to Mission Winnow.
    Dewhirst T; Lee WB; Czaplicki L
    Nicotine Tob Res; 2023 Nov; 25(12):1838-1846. PubMed ID: 37702346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded 'Project Star' report.
    Gilmore AB; Rowell A; Gallus S; Lugo A; Joossens L; Sims M
    Tob Control; 2014 May; 23(e1):e51-61. PubMed ID: 24335339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.
    Elias J; Hendlin YH; Ling PM
    PLoS Med; 2018 May; 15(5):e1002562. PubMed ID: 29715300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeking to be seen as legitimate members of the scientific community? An analysis of British American Tobacco and Philip Morris International's involvement in scientific events.
    Matthes BK; Fabbri A; Dance S; Laurence L; Silver K; Gilmore AB
    Tob Control; 2024 Jun; 33(4):464-471. PubMed ID: 36737249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence.
    van der Eijk Y; Bero LA; Malone RE
    Tob Control; 2019 Nov; 28(6):712-718. PubMed ID: 30242044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMI's heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products.
    McKelvey K; Baiocchi M; Halpern-Felsher B
    Tob Control; 2020 Dec; 29(e1):e18-e24. PubMed ID: 32029537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco industry's elaborate attempts to control a global track and trace system and fundamentally undermine the Illicit Trade Protocol.
    Gilmore AB; Gallagher AWA; Rowell A
    Tob Control; 2019 Mar; 28(2):127-140. PubMed ID: 29899082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mainstream emissions, secondhand emissions and the environmental impact of IQOS waste: a systematic review on IQOS that accounts for data source.
    El-Kaassamani M; Yen M; Talih S; El-Hellani A
    Tob Control; 2022 May; ():. PubMed ID: 35568394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.